Literature DB >> 7542571

Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.

M C Nash1, V Shah, M J Dillon.   

Abstract

Fifty-nine children with acute Kawasaki disease (KD), a childhood vasculitis, were compared with 35 children with fever due to infection and 48 healthy children. Levels of soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) in the healthy children were double those found in adults. All three soluble cell adhesion molecules and von Willebrand factor (vWF) were higher in the children with KD than in the healthy children, but only sE-selectin, a marker for activated endothelial cells, and sICAM-1 were higher than in the febrile children. The high levels of vWF in KD appear to reflect the prominent acute-phase reaction. This information can help us to understand further the complex interactions between cytokines, circulating inflammatory cells and the vascular endothelium, and may lead to new therapeutic avenues in KD and other inflammatory diseases and vasculitides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542571      PMCID: PMC1553297          DOI: 10.1111/j.1365-2249.1995.tb02270.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Diagnostic guidelines for Kawasaki disease. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease.

Authors: 
Journal:  Am J Dis Child       Date:  1990-11

Review 2.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

3.  von Willebrand factor is an acute phase reactant in man.

Authors:  B E Pottinger; R C Read; E M Paleolog; P G Higgins; J D Pearson
Journal:  Thromb Res       Date:  1989-02-15       Impact factor: 3.944

4.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

5.  von Willebrand factor and endothelial damage in essential hypertension.

Authors:  A D Blann; T Naqvi; M Waite; C N McCollum
Journal:  J Hum Hypertens       Date:  1993-04       Impact factor: 3.012

6.  Factor VIII related antigen and childhood rheumatic diseases.

Authors:  S L Bowyer; C G Ragsdale; D B Sullivan
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

7.  IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.

Authors:  M H Thornhill; D O Haskard
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

8.  Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1.

Authors:  J C Mason; P Kapahi; D O Haskard
Journal:  Arthritis Rheum       Date:  1993-04

9.  Factor VIII related antigen (von Willebrand's factor) in Kawasaki disease.

Authors:  J E Irazuzta; F Elbl; A R Rees
Journal:  Clin Pediatr (Phila)       Date:  1990-06       Impact factor: 1.168

10.  Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.

Authors:  D Y Leung; R S Cotran; E Kurt-Jones; J C Burns; J W Newburger; J S Pober
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

View more
  15 in total

1.  Lipid peroxidation and Kawasaki disease.

Authors:  F D Faro; J C Burns
Journal:  Pediatr Cardiol       Date:  2003-06-06       Impact factor: 1.655

2.  Von Willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease.

Authors:  André Jakob; Eva Schachinger; Simon Klau; Anja Lehner; Sarah Ulrich; Brigitte Stiller; Barbara Zieger
Journal:  Eur J Pediatr       Date:  2019-11-23       Impact factor: 3.183

Review 3.  Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.

Authors:  P P Sfikakis; G C Tsokos
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura.

Authors:  O Söylemezoglu; N Sultan; T Gursel; N Buyan; E Hasanoglu
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

5.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

6.  Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.

Authors:  J C Burns; C Shimizu; H Shike; J W Newburger; R P Sundel; A L Baker; T Matsubara; Y Ishikawa; V A Brophy; S Cheng; M A Grow; L L Steiner; N Kono; R M Cantor
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

7.  Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-Americans.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Kyoungmi Kim; Lars Berglund
Journal:  Atherosclerosis       Date:  2015-02-16       Impact factor: 5.162

8.  Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura.

Authors:  M Fujieda; N Oishi; K Naruse; M Hashizume; K Nishiya; T Kurashige; K Ito
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

9.  Genetic polymorphisms in the CD40 ligand gene and Kawasaki disease.

Authors:  Fu-Yuan Huang; Tzu-Yang Chang; Ming-Ren Chen; Nan-Chang Chiu; Hsin Chi; Hung-Chang Lee; Shuan-Pei Lin; Chih-Kai Chen; Hui-Wen Chan; Wei-Fang Chen; Hsin-Fu Liu; Chen-Chung Chu; Marie Lin; Yann-Jinn Lee
Journal:  J Clin Immunol       Date:  2008-05-15       Impact factor: 8.317

10.  The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies.

Authors:  E Grunebaum; M Blank; S Cohen; A Afek; J Kopolovic; P L Meroni; P Youinou; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.